EMAIL DETAILS
SUBJECT:
Fwd: 742P003-China (Method of Manufacturing Antimicrobial Implants . . .)
PRI: NORMAL
FROM:
P
perowan@gmail.com
DATE:
2014-12-10 14:15:44
MSG_ID:
<217E61F6-F478-4227-8C53-1040EFE098B7@gmail.com>
RECIPIENTS:
TO:
E
Eric Schwerin
<eschwerin@rosemontseneca.com>
R
Hunter
<rhb@rspdc.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
FYI - pls forward to Arlene Sent from my iPhone Begin forwarded message: > From: Derrick Johns <derrick@difusiontech.com> > Date: December 10, 2014 at 8:44:05 AM EST > To: Brian Parker <brian@pharmaguard.ie> > Subject: FW: 742P003-China (Method of Manufacturing Antimicrobial Implants . . .) > > Whoop there it is… > > From: Kevin Lemack <kevin.lemack@iplawboutique.com> > Date: Wednesday, December 10, 2014 at 7:36 AM > To: Derrick Johns <derrick@difusiontech.com>, <SRodain@aol.com> > Subject: 742P003-China (Method of Manufacturing Antimicrobial Implants . . .) > > Derrick and Joe: > > We just received word that our manufacturing patent application has been allowed in China. Our formal report will follow. > > Regards, > > Kevin > Nields, Lemack & Frame, LL
METADATA:
THREAD:
INDEX:
AdhhoAMiq87SegsHQ4G/6AZX5BIjsQ==
REFERENCES:
REFS:
<D0ADAA31.1D8BD%derrick@difusiontech.com>